本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Dianthus Therapeutics Inc.

37.90
+2.336.55%
盘后35.80-2.1000-5.54%19:30 EDT
成交量:286.09万
成交额:1.04亿
市值:12.20亿
市盈率:-11.67
高:38.25
开:33.89
低:33.23
收:35.57
52周最高:38.25
52周最低:13.37
股本:3,218.83万
流通股本:1,345.91万
量比:1.52
换手率:21.26%
股息:- -
股息率:- -
每股收益(TTM):-3.2490
每股收益(LYR):-2.5506
净资产收益率:-34.71%
总资产收益率:-23.37%
市净率:4.03
市盈率(LYR):-14.86

数据加载中...

2024/02/08

SEC问询函

Form CORRESP - Correspondence
2024/02/07

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2024/02/02

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/02

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/01/31

超过5%披露

Form SC 13D - General statement of acquisition of beneficial ownership
2024/01/25

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/01/22

重要事件披露

Form 8-K - Current report
2024/01/08

重要事件披露

Form 8-K - Current report
2023/12/22

重要事件披露

Form 8-K - Current report
2023/12/21

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2023/11/10

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/10

重要事件披露

Form 8-K - Current report
2023/10/25

重要事件披露

Form 8-K - Current report
2023/10/05

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2023/09/21

重要事件披露

Form 8-K/A - Current report: [Amend]
2023/09/21

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/09/21

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/09/21

超过5%披露

Form SC 13D - General statement of acquisition of beneficial ownership
2023/09/21

超过5%披露

Form SC 13D - General statement of acquisition of beneficial ownership
2023/09/15

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]